These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7981459)
1. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Powles TJ; Jones AL; Ashley SE; O'Brien ME; Tidy VA; Treleavan J; Cosgrove D; Nash AG; Sacks N; Baum M Breast Cancer Res Treat; 1994; 31(1):73-82. PubMed ID: 7981459 [TBL] [Abstract][Full Text] [Related]
2. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of breast cancer. Powles TJ; Hardy JR; Ashley SE; Cosgrove D; Davey JB; Dowsett M; McKinna A; Nash AG; Rundle SK; Sinnett HD Breast Cancer Res Treat; 1989 Oct; 14(1):23-31. PubMed ID: 2690969 [TBL] [Abstract][Full Text] [Related]
4. Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Powles TJ; Tillyer CR; Jones AL; Ashley SE; Treleaven J; Davey JB; McKinna JA Eur J Cancer; 1990; 26(6):680-4. PubMed ID: 2144154 [TBL] [Abstract][Full Text] [Related]
5. The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Chang J; Powles TJ; Ashley SE; Gregory RK; Tidy VA; Treleaven JG; Singh R Ann Oncol; 1996 Sep; 7(7):671-5. PubMed ID: 8905024 [TBL] [Abstract][Full Text] [Related]
6. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Veronesi U; Maisonneuve P; Costa A; Sacchini V; Maltoni C; Robertson C; Rotmensz N; Boyle P Lancet; 1998 Jul; 352(9122):93-7. PubMed ID: 9672273 [TBL] [Abstract][Full Text] [Related]
7. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women]. Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849 [TBL] [Abstract][Full Text] [Related]
8. Should tamoxifen be used in breast cancer prevention? Kramer R; Brown P Drug Saf; 2004; 27(13):979-89. PubMed ID: 15471505 [TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236 [TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of breast cancer. Osborne MP Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment. Veronesi A; Pizzichetta MA; Ferlante MA; Zottar M; Magri MD; Crivellari D; Foladore S Tumori; 1998; 84(3):372-5. PubMed ID: 9678620 [TBL] [Abstract][Full Text] [Related]
12. Future possibilities in the prevention of breast cancer: breast cancer prevention trials. Cuzick J Breast Cancer Res; 2000; 2(4):258-63. PubMed ID: 11250718 [TBL] [Abstract][Full Text] [Related]
13. The Royal Marsden Hospital (RMH) trial: key points and remaining questions. Powles TJ Ann N Y Acad Sci; 2001 Dec; 949():109-12. PubMed ID: 11795342 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of breast cancer. Powles TJ; Davey J; McKinna A Acta Oncol; 1989; 28(6):865-7. PubMed ID: 2692649 [TBL] [Abstract][Full Text] [Related]
15. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305 [TBL] [Abstract][Full Text] [Related]
16. Update on breast cancer prevention. Rastogi P; Vogel VG Oncology (Williston Park); 2003 Jun; 17(6):799-805; discussion 808-10, 813. PubMed ID: 12846124 [TBL] [Abstract][Full Text] [Related]
17. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306 [TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U; Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284 [TBL] [Abstract][Full Text] [Related]
19. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Powles TJ; Hardy JR; Ashley SE; Farrington GM; Cosgrove D; Davey JB; Dowsett M; McKinna JA; Nash AG; Sinnett HD Br J Cancer; 1989 Jul; 60(1):126-31. PubMed ID: 2679843 [TBL] [Abstract][Full Text] [Related]
20. [Breakthrough in breast cancer chemoprevention]. Kahán Z; Thurzó L Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]